These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1900244)

  • 1. 1-(substituted)benzyl-5-aminoimidazole-4-carboxamides are potent orally active inhibitors of Trypanosoma cruzi in mice.
    Chabala JC; Waits VB; Ikeler T; Patchett AA; Payne L; Peterson LH; Reamer RA; Hoogsteen K; Wyvratt M; Hanson WL
    Experientia; 1991 Jan; 47(1):51-3. PubMed ID: 1900244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
    Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
    Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In pursuit of drugs for American trypanosomiasis: evaluation of some "standards" in a mouse model.
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Proc Soc Exp Biol Med; 1997 Dec; 216(3):424-8. PubMed ID: 9402149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi: efficacy of the 2-substituted, 5-nitroimidazoles, MK-436 and L634,549, in tissue culture and mice.
    Murray PK; Habbersett MC; Meurer RD
    Am J Trop Med Hyg; 1983 Nov; 32(6):1242-50. PubMed ID: 6418014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structural elucidation and in vitro antiparasitic activity against Trypanosoma cruzi and Leishmania chagasi parasites of novel tetrahydro-1-benzazepine derivatives.
    Gómez-Ayala S; Castrillón JA; Palma A; Leal SM; Escobar P; Bahsas A
    Bioorg Med Chem; 2010 Jul; 18(13):4721-39. PubMed ID: 20627590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model.
    Olmo F; Guardia JJ; Marin C; Messouri I; Rosales MJ; Urbanová K; Chayboun I; Chahboun R; Alvarez-Manzaneda EJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Jan; 89():683-90. PubMed ID: 25462275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.
    Saccoliti F; Madia VN; Tudino V; De Leo A; Pescatori L; Messore A; De Vita D; Scipione L; Brun R; Kaiser M; Mäser P; Calvet CM; Jennings GK; Podust LM; Costi R; Di Santo R
    Eur J Med Chem; 2018 Aug; 156():53-60. PubMed ID: 30006174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary studies on the efficacy of Bayer 2502 (lampit) for treatment of Trypanosoma cruzi (strain 7) infection in CF1 mice.
    Marsden PD; Miles MA; Patterson JW; Pettitt LE
    Trans R Soc Trop Med Hyg; 1972; 66(3):508-9. PubMed ID: 4625718
    [No Abstract]   [Full Text] [Related]  

  • 9. Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity.
    Aguilera E; Varela J; Birriel E; Serna E; Torres S; Yaluff G; de Bilbao NV; Aguirre-López B; Cabrera N; Díaz Mazariegos S; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Minini L; Merlino A; Cerecetto H; González M; Alvarez G
    ChemMedChem; 2016 Jun; 11(12):1328-38. PubMed ID: 26492824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.
    Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D
    J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections.
    Yardley V; Croft SL
    Am J Trop Med Hyg; 1999 Aug; 61(2):193-7. PubMed ID: 10463666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [(Effect of Lampit on experimental Trypanosoma cruzi infection in mice)].
    Apt W; Mancilla R; Díaz M; Díaz S
    Bol Chil Parasitol; 1972; 27(3):80-6. PubMed ID: 4196829
    [No Abstract]   [Full Text] [Related]  

  • 13. Trypanosoma cruzi: 4-aminopyrazolopyrimidine in the treatment of experimental Chagas' disease.
    Avila JL; Avila A; Muñoz E; Monzón H
    Exp Parasitol; 1983 Oct; 56(2):236-40. PubMed ID: 6413238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
    Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of fexinidazole (HOE 239) against experimental infections with Trypanosoma cruzi, trichomonads and Entamoeba histolytica.
    Raether W; Seidenath H
    Ann Trop Med Parasitol; 1983 Feb; 77(1):13-26. PubMed ID: 6411009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentamidine exerts in vitro and in vivo anti Trypanosoma cruzi activity and inhibits the polyamine transport in Trypanosoma cruzi.
    Díaz MV; Miranda MR; Campos-Estrada C; Reigada C; Maya JD; Pereira CA; López-Muñoz R
    Acta Trop; 2014 Jun; 134():1-9. PubMed ID: 24560964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
    Palace-Berl F; Pasqualoto KFM; Zingales B; Moraes CB; Bury M; Franco CH; da Silva Neto AL; Murayama JS; Nunes SL; Silva MN; Tavares LC
    Eur J Med Chem; 2018 Jan; 144():29-40. PubMed ID: 29247858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Lampit on Trypanosoma rangeli in experimentally infected mice.
    Marinkelle CJ
    Tropenmed Parasitol; 1982 Sep; 33(3):151-2. PubMed ID: 6814024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
    Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
    Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.